Supernus Pharmaceuticals, Inc. (SUPN)

50.48 -0.96 (-1.87%) USD  |  NASDAQ  |  Apr 02, 16:00
50.44 -0.04 (-0.08%) Pre-Market: 20:00
More

Supernus Pharmaceuticals EBIT (% of Annual Revenues)

EBIT (% of Annual Revenues) Chart

View EBIT (% of Annual Revenues) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (% of Annual Revenues) Range, Past 5 Years

View EBIT (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (% of Annual Revenues) Benchmarks

View EBIT (% of Annual Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade